INSIDER · CIK 1121404
Sanofi
10% Owner at Latigo Biotherapeutics, Inc. (LTGO) · 10% Owner at Attovia Therapeutics, Inc. (ATTO)
↗3 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$5.1MBought on the market
$0.00Sold on the market
2Companies
Aug 12, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 202608:18 | Aug 10, 2026 | LTGOLatigo Biotherapeutics, Inc. | 10% Owner | C · Convert | — | +672,778 | 672,788 | +6727780% | — | ||
| Aug 7, 202615:45 | Aug 6, 2026 | ATTOAttovia Therapeutics, Inc. | 10% Owner | P · Buy | $17.00 | +300,000 | 1,082,855 | +38% | +$5.1M | -22.4% | -7.1% |
| Aug 7, 202615:45 | Aug 6, 2026 | ATTOAttovia Therapeutics, Inc. | 10% Owner | C · Convert | — | +782,855 | 782,855 | New | — |